Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · IEX Real-Time Price · USD
3.650
-0.080 (-2.14%)
At close: May 17, 2024, 4:00 PM
3.700
+0.050 (1.37%)
After-hours: May 17, 2024, 7:51 PM EDT

Acumen Pharmaceuticals Statistics

Total Valuation

ABOS has a market cap or net worth of $218.84 million. The enterprise value is -$3.32 million.

Market Cap 218.84M
Enterprise Value -3.32M

Important Dates

The last earnings date was Tuesday, May 14, 2024, before market open.

Earnings Date May 14, 2024
Ex-Dividend Date n/a

Share Statistics

ABOS has 60.08 million shares outstanding. The number of shares has increased by 45.79% in one year.

Shares Outstanding 60.08M
Shares Change (YoY) +45.79%
Shares Change (QoQ) +3.10%
Owned by Insiders (%) 11.24%
Owned by Institutions (%) 73.65%
Float 32.28M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.84
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 30.20, with a Debt / Equity ratio of 0.12.

Current Ratio 30.20
Quick Ratio n/a
Debt / Equity 0.12
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -34.38

Financial Efficiency

Return on equity (ROE) is -22.90% and return on invested capital (ROIC) is -22.48%.

Return on Equity (ROE) -22.90%
Return on Assets (ROA) -20.80%
Return on Capital (ROIC) -22.48%
Revenue Per Employee n/a
Profits Per Employee -$1.10M
Employee Count 51
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -33.03% in the last 52 weeks. The beta is 0.19, so ABOS's price volatility has been lower than the market average.

Beta (1Y) 0.19
52-Week Price Change -33.03%
50-Day Moving Average 3.71
200-Day Moving Average 3.91
Relative Strength Index (RSI) 54.17
Average Volume (30 Days) 309,204

Short Selling Information

The latest short interest is 926,852, so 1.54% of the outstanding shares have been sold short.

Short Interest 926,852
Short Previous Month 1.05M
Short % of Shares Out 1.54%
Short % of Float 2.87%
Short Ratio (days to cover) 4.05

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -65.78M
Pretax Income -55.94M
Net Income -55.94M
EBITDA -54.18M
EBIT -54.36M
Earnings Per Share (EPS) -$1.06
Full Income Statement

Balance Sheet

The company has $252.75 million in cash and $30.58 million in debt, giving a net cash position of $222.16 million or $3.70 per share.

Cash & Cash Equivalents 252.75M
Total Debt 30.58M
Net Cash 222.16M
Net Cash Per Share $3.70
Equity / Book Value 262.03M
Book Value Per Share 4.36
Working Capital 247.36M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$50.75 million and capital expenditures -$29,000, giving a free cash flow of -$50.78 million.

Operating Cash Flow -50.75M
Capital Expenditures -29,000
Free Cash Flow -50.78M
FCF Per Share -$0.85
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ABOS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -45.79%
Shareholder Yield -45.79%
Earnings Yield -25.56%
FCF Yield -23.20%

Analyst Forecast

The average price target for ABOS is $12.60, which is 245.21% higher than the current price. The consensus rating is "Strong Buy".

Price Target $12.60
Price Target Difference 245.21%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) 1.84%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2